The chart was, in truth, a parody of analysis. Even the presenter acknowledged it was unlikely. But that was never the point. The intent was to frame stakeholder calls for greater investment in innovative health technologies as a direct threat to national solvency. The underlying message was clear. The demand is against the national interest. …
The continued 'false framing' aims to make us feel guilty for wanting more on health
October 31, 2025 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Nurse prescribing reform set to expand access to PBS subsidised medicines
July 3, 2026 - - Latest News -
Cartherics emerges as Asia Pacific leader in off-the-shelf immune cell therapy
July 2, 2026 - - Australian Biotech -
Minister looks to be sending a very clear message about these therapies and the PBS
July 2, 2026 - - Latest News -
The end-game of strong-arming companies over prices at the expense of patients and process
July 2, 2026 - - Latest News -
Commercial outsourcing emerges as a strategic option to patient access
July 1, 2026 - - Latest News -
The minister is following a tried and tested process, but what is the risk in this new world?
July 1, 2026 - - Latest News -
Patient alarm over the potential loss of subsidised access to MS medicines
July 1, 2026 - - Latest News